Jessica Charron, NP
Adult Health · Chicago, ILNPI 1427238823
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,375 of the $4,680 with a category attached, or 72.1%. 5 manufacturers reported payments, led by Biosense Webster, Inc. at 42.7% of the total. Reporting peaked in 2022 at $2,372 and has fallen 88.4% since, to $275 in 2025. Among adult health clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $90.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$2K
- Altathera Pharmaceuticals LLC$2K
- Medtronic$831
- Boston Scientific$325
- Atricure, Inc.$20
What the payments were for
- Consulting fees$3,37572%
- Food & beverage$1,30528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 1 | $2,000 |
| Altathera Pharmaceuticals LLC | 2 | $1,504 |
| Medtronic | 42 | $831 |
| Boston Scientific | 6 | $325 |
| Atricure, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sotalol Hydrochloride$1,504
- EMBLEM MRI S-ICD$188
How this compares
$4,680 in reported general payments places this provider in the 90th percentile of 553 adult health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 12 | $170 |
Paid to pharmacies, not to this prescriber.
Other adult health in Chicago
- Colleen FolkersChicago$86K
- Matthew BurkeChicago$44K
- Jacklyn GideonChicago$38K
- Jennifer GreenfieldChicago$35K
- Tammy PomaChicago$32K
- Cecille CruzChicago$15K
- Margaret SchwartzChicago$14K
- Karen MeehanChicago$8K
- Michelle EversChicago$8K
- Keriann KordasChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.